Back
Bicycle Therapeutics PLC Stock Predictions
Legendary Investor: "It's Time to Buy These 3 Made-in-America Stocks"
He's now recommending these Three Stocks for Trump's New Industrial Boom.
Sell
24
BCYC
Bicycle Therapeutics PLC
Last Price:
$7.64
Seasonality Move:
12.38%
7 Day Trial
ALL ACCESS PASS
$
7
Why Trump Could Send These 3 Stocks Soaring
According to legendary investor Louis Navellier, these three "Made in America" stocks are set to benefit from this coming boom.Bicycle Therapeutics PLC Stock Forecast
-
Over the next 52 weeks, Bicycle Therapeutics PLC has on average historically risen by 18.8% based on the past 6 years of stock performance.
-
Bicycle Therapeutics PLC has risen higher in 2 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Bicycle Therapeutics PLC Stock Undervalued?The current Bicycle Therapeutics PLC [BCYC] share price is $7.65. The Score for BCYC is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
BCYC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Bicycle Therapeutics PLC Stock Go Up Next Year?
-
Over the next 52 weeks, Bicycle Therapeutics PLC has on average historically risen by 18.8% based on the past 6 years of stock performance.
Bicycle Therapeutics PLC Stock Rating
Sell
24
Bicycle Therapeutics PLC (BCYC)
is a Sell
Is Bicycle Therapeutics PLC overpriced?
-
Bicycle Therapeutics PLC has risen higher in 2 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Bicycle Therapeutics PLC Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bicycletherapeutics.com
52-Week Data
52-Week High:
28.67
52-Week Low:
6.10
Prediction Charts
Market Cap:
529.8M
Price in USD:
7.65
Volume:
256K
Beta:
0.88
Technical Analysis
SMA50:
8.00
SMA100:
8.09
SMA200:
12.41
52-Wk Change:
-66.68%
Stock Predictions
-
Is Bicycle Therapeutics PLC stock public?Yes, Bicycle Therapeutics PLC is a publicly traded company.
-
What is the Bicycle Therapeutics PLC stock quote today?The Bicycle Therapeutics PLC stock price is 7.65 USD today.
-
How to buy Bicycle Therapeutics PLC stock online?You can buy Bicycle Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Jul-22 | 8.31 | 8.37 | 8.70 | 8.21 |
| Jul-23 | 8.40 | 8.71 | 9.18 | 8.38 |
| Jul-24 | 8.70 | 8.60 | 8.89 | 8.58 |
| Jul-25 | 8.68 | 8.70 | 8.91 | 8.51 |
| Jul-28 | 8.73 | 8.61 | 8.90 | 8.52 |
| Jul-29 | 8.56 | 8.52 | 8.61 | 8.40 |
| Jul-30 | 8.68 | 8.51 | 8.88 | 8.46 |
| Jul-31 | 8.39 | 8.52 | 8.73 | 8.39 |
| Aug-1 | 8.31 | 7.99 | 8.45 | 7.89 |
| Aug-4 | 7.99 | 8.05 | 8.15 | 7.93 |
| Aug-5 | 8.04 | 7.86 | 8.19 | 7.77 |
| Aug-6 | 7.81 | 7.56 | 7.98 | 7.54 |
| Aug-7 | 7.56 | 7.46 | 7.64 | 7.36 |
| Aug-8 | 7.55 | 7.65 | 7.98 | 7.44 |
Bicycle Therapeutics PLC Earnings
Bicycle Therapeutics PLC Earnings Report: Per Share Bicycle Therapeutics PLC Earnings Q1 Q2 Q3 and Q4 last year and next year.
Bicycle Therapeutics PLC Forecast Revenue Growth
Bicycle Therapeutics PLC Stock Analysis: Historical quarterly revenues per share for Bicycle Therapeutics PLC and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.81 per share, and a decrease next year of $0.42 per share.
* Bicycle Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.